Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.

Psychiatrike = Psychiatriki - 1 Jan 2000

Tsermpini E E, Skokou M, Ferentinos P, Georgila E, Gourzis P, Assimakopoulos K, Patrinos G P

Abstract excerpt

PREemptive Pharmacogenomic testing for Preventing Adverse drug REactions (PREPARE) is the first prospective, pre-emptive pharmacogenomic study conducted in Europe, within the frame of the Horizon 2020 program. It aims to determine whether implementing pre-emptive pharmacogenomics (PGx) testing of clinically relevant biomarkers, so as the dose and drug selection to be guided, will result in an overall reduction of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Pharmacological

Share to Cytochrome P-450 CYP2C19

Share to Cytochrome P-450 CYP2D6

Share to Drug-Related Side Effects and Adverse Reactions

Share to Mental Disorders

Share to Precision Medicine

Source

Identifiers

PMID: 33361064
DOI: 10.22365/jpsych.2020.314.341

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.PMID 33361064Read ↗

Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.Semantic proximity Read ↗

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.Semantic proximity Read ↗

Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?Semantic proximity Read ↗

Influence of metabolic profiles on the safety of drug therapy in routine care in Germany: protocol of the cohort study EMPAR.Semantic proximity Read ↗

Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice.Semantic proximity Read ↗

Pharmacogenetics in Psychiatry: An Update on Clinical UsabilitySemantic proximity Read ↗

Use of Pharmacogenetic Drugs by the Dutch PopulationSemantic proximity Read ↗

The role of pharmacogenomics in adverse drug reactionsSemantic proximity Read ↗

What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?Semantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.Semantic proximity Read ↗

Pharmacogenetic and Pharmacogenomic Research in Psychiatry: Current Advances and Clinical Applications.Semantic proximity Read ↗

Genetic diversity of cytochrome P450 in patients receiving psychiatric care in Greece: a step towards clinical implementation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.